Article citationsMore>>

N. J. Senff, E. M. Noordijk, Y. H. Kim, M. Bagot, et al., “European Organization for Research and Treatment of Cancer; International Society for Cutaneous Lymphoma. European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma Consensus Recommendations for the Management of Cutaneous B-Cell Lymphomas,” Blood, Vol. 112, No. 5, 2008, pp. 1600-1609. doi:10.1182/blood-2008-04-152850

has been cited by the following article:

• TITLE: Primary Cutaneous MZL with Amyloid Deposition, Initially Misdiagnosed as Amyloidosis Mimics Primary Dural MZL upon Dural Dissemination

  AUTHORS: Miaoxia He, Lili Wu, Minghua Zhu, Chenguang Bai, Shimin Zhang, Jianjun Wang

  KEYWORDS: Skin; Dura; Amyloid Deposition; MZL; Dissemination

  JOURNAL NAME: Open Journal of Pathology, Vol.3 No.1, January 28, 2013

  ABSTRACT: Primary cutaneous marginal zone B-cell lymphoma (MZL) is considered a cutaneous counterpart of extranodal MZL of mucosa-associated lymphoid tissue and an indolent lymphoma. Amyloid deposition in this tumor is very rare. We report here a case of primary cutaneous MZL with massive amyloid deposition. The tumor disseminated to the dura and mimicked primary dural MZL. The patient had a four year history of the recurrence cutaneous lesions with a misdiagnosis of amyloidosis. The correct diagnosis was made after the metastatic dural lesion was confirmed by radiology, pathology and molecular biology approaches. It is of crucial importance for differential diagnosis to avoid misdiagnosis and the patients are indeed required long-term regular examinations and treatment because of the possibility of recurrence or dissemination.